tiprankstipranks
Blurbs

Analysts Conflicted on These Technology Names: Infosys (INFY), Sunny Optical Technology (Group) Co (OtherSNPTF) and Morphic Holding (MORF)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Infosys (INFYResearch Report), Sunny Optical Technology (Group) Co (SNPTFResearch Report) and Morphic Holding (MORFResearch Report).

Infosys (INFY)

In a report released yesterday, Keith Bachman from BMO Capital maintained a Hold rating on Infosys, with a price target of $18.00. The company’s shares closed last Thursday at $16.46.

According to TipRanks.com, Bachman is a 5-star analyst with an average return of 7.2% and a 57.4% success rate. Bachman covers the Technology sector, focusing on stocks such as International Business Machines, CrowdStrike Holdings, and Rackspace Technology.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Infosys with a $17.50 average price target, implying a 6.7% upside from current levels. In a report issued on October 4, J.P. Morgan also upgraded the stock to Hold with a $16.80 price target.

See the top stocks recommended by analysts >>

Sunny Optical Technology (Group) Co (SNPTF)

In a report released today, Alex NG from CMB International Securities reiterated a Hold rating on Sunny Optical Technology (Group) Co, with a price target of HK$64.08. The company’s shares closed last Wednesday at $6.95, close to its 52-week low of $6.93.

According to TipRanks.com, NG is ranked #7205 out of 8568 analysts.

Sunny Optical Technology (Group) Co has an analyst consensus of Hold, with a price target consensus of $8.18.

Morphic Holding (MORF)

In a report released today, Evan Seigerman from BMO Capital assigned a Buy rating to Morphic Holding, with a price target of $52.00. The company’s shares closed last Thursday at $21.89, close to its 52-week low of $19.80.

According to TipRanks.com, Seigerman is a 4-star analyst with an average return of 6.3% and a 45.8% success rate. Seigerman covers the Healthcare sector, focusing on stocks such as Structure Therapeutics, Inc. Sponsored ADR, Vertex Pharmaceuticals, and Bristol-Myers Squibb.

Morphic Holding has an analyst consensus of Moderate Buy, with a price target consensus of $65.50.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on INFY:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles